Lifecore Biomedical, Inc. (LFCR)

NASDAQ: LFCR · USD

$6.50

+0.06 (+0.9%)· Recorded snapshot

Market cap	246M
Revenue (ttm)	129.5M
Net income (ttm)	-34.5M
EPS (ttm)	-$0.93
Shares out	37.9M
Volume	328,421
Beta	0.98

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 129.5M
Net income (ttm): -34.5M
EPS (ttm): -$0.93
Market cap: 246M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-0.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LFCR indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001005286
Company name	Lifecore Biomedical, Inc.
Country	United States
Country code	US
CUSIP number	514766104
Earnings date	2026-11-09
Earnings time	amc
Employees	382
Employees change	-24
Employees growth	-5.91%
Enterprise value	$372.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1986
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US5147661046
Last 10-K release date	2025-08-07
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$246M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$6.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LFCR
U.S. state	Minnesota
Website	https://www.lifecore.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.24%
EV/EBITDA	45.22x
EV/FCF	59.82x
EV/Sales	2.88x
FCF / EV yield	1.67%
FCF yield	2.53%
Forward EV/Sales	2.96x
Forward P/S	1.96x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(OCF - SBC) ratio	86.65x
P/B ratio	7.23x
P/FCF ratio	39.56x
P/OCF ratio	19.61x
P/S ratio	1.9x
Price/EBITDA ratio	29.9x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-0.97%
EBITDA margin	6.37%
FCF margin	4.81%
Gross margin	31.37%
Operating margin	-0.97%
Pretax margin	-23.34%
Profit margin	-23.78%
Profit per employee	$-90,323
Revenue per employee	$338,913
ROCE	-0.6%
ROIC	-0.76%
ROIC (5Y)	-4.63%
SBC / revenue	7.51%
Tax / revenue	0.45%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-8.76%
Gross profit growth (Q)	-13.64%
Gross profit growth 3Y	5.47%
Gross profit growth 5Y	-11.64%
Net income growth years	0
OCF growth	68.24%
OCF growth 10Y	-4.75%
OCF growth 5Y	18.32%
Operating income growth (Q)	-11.45%
Revenue growth	0.8%
Revenue growth (Q)	-6.25%
Revenue growth (QoQ)	47.32%
Revenue growth 10Y	-13.32%
Revenue growth 3Y	11.51%
Revenue growth 5Y	-26.1%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6.3M
Depreciation and amortization	$9.5M
EBIT	$-1.3M
EBITDA	$8.2M
EPS	$-0.93
FCF per share	$0.16
Financing cash flow	$-7.6M
Free cash flow	$6.2M
Free cash flow minus SBC	$-3.5M
Gross profit	$40.6M
Income taxes	$577,714
Investing cash flow	$10.8M
Net borrowing	$-4.3M
Net cash flow	$15.8M
Net income	$-34.5M
Operating cash flow minus SBC	$2.8M
Operating income	$-1.3M
Revenue	$129.5M
Stock-based compensation	$9.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.29
Book value per share	$-0.38
Debt / EBITDA	16.83
Debt / equity	4.22
Debt / FCF	23.07
Goodwill	$13.9M
Interest coverage	-0.05
Long-term assets	$148.5M
Long-term liabilities	$176.5M
Net cash (debt)	$-126.3M
Net cash / market cap	-51.24%
Net debt / EBITDA	15.32
Net debt / equity	3.71
Net debt / FCF	20.27
Piotroski F-Score	3
Property, plant and equipment	$123.7M
Shareholders' equity	$34.1M
Tangible book value	$-32.3M
Tangible book value per share	$-0.86
Total assets	$232.2M
Total cash	$17.5M
Total debt	$143.7M
Total liabilities	$198.1M
WACC	11.59%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$83.7M
Current liabilities	$21.6M
Current ratio	3.49
Net working capital	$42.6M
Quick ratio	2.18
Working capital	$58.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.63%
Dividend yield	0%
Shareholder yield	-1.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-51.13%
10Y return CAGR	-6.91%
10Y total return	-51.13%
150-day SMA	$5.02
15Y price change	-0.31%
15Y return CAGR	-0.02%
15Y total return	-0.31%
1D price change	0.93%
1M price change	54.76%
1M total return	54.76%
1W price change	2.04%
1W total return	2.04%
1Y price change	-3.42%
1Y return CAGR	-3.42%
1Y total return	-3.42%
20-day SMA	$6.44
200-day SMA	$5.52
20Y price change	-32.5%
20Y return CAGR	-1.95%
20Y total return	-32.5%
3M price change	49.77%
3M total return	49.77%
3Y price change	-7.54%
3Y return CAGR	-2.58%
3Y total return	-7.54%
50-day SMA	$5.34
50-day SMA vs 200-day SMA	50under200
52-week high	$8.98
52-week high date	2026-01-27
52-week low	$3.63
52-week low date	2026-03-31
5Y price change	-30.48%
5Y return CAGR	-7.01%
5Y total return	-30.48%
6M price change	27.95%
6M total return	27.95%
All-time high	$20.75
All-time high date	1996-05-22
All-time low	$1.51
All-time low date	2002-09-13
Average true range (ATR)	$0.12
Average volume	570.3K
Beta (1Y)	2.25
Beta (2Y)	1.85
Beta (5Y)	0.98
Change from 52-week high	-27.62%
Change from 52-week low	79.31%
Change from all-time high	-68.67%
Change from all-time low	330.46%
Change from open	1.09%
Day's gap	-0.16%
Dollar volume	$2.1M
High price	$6.51
Low price	$6.43
Monthly RSI	50.56
Open price	$6.43
Position in 52-week range	87.5%
Previous close	$6.44
Price vs 150-day SMA	29.53%
Price vs 20-day SMA	0.98%
Price vs 200-day SMA	17.69%
Price vs 50-day SMA	21.65%
Relative volume	0.58
RSI	74.1
Sharpe ratio	0.28
Sharpe ratio (3Y)	0.27
Sharpe ratio (5Y)	0.3
Sortino ratio	0.58
Sortino ratio (3Y)	0.48
Sortino ratio (5Y)	0.55
Volume	328.4K
Weekly RSI	60.39
YTD price change	-20.54%
YTD total return	-20.54%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.3M
Float percentage	51.1%
Shares change (QoQ)	0.26%
Shares change (YoY)	1.63%
Shares held by insiders	3.75%
Shares held by institutions	27.35%
Shares outstanding	37.9M
Short % of float	12.8%
Short % of shares	6.54%
Short ratio	6.3 days

Deeper analysis on LFCR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LFCR report

Is a complete LFCR research report available?

No complete published report is available for Lifecore Biomedical, Inc. (LFCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lifecore Biomedical, Inc. (LFCR)

Price

Financial snapshot

Fair-value bridge

Latest news · LFCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LFCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LFCR

Frequently asked questions